| 华蕾,王春杰,李明霞,等.贫血与弥漫大 B细胞淋巴瘤病人的预后相关性[J].安徽医药,2019,23(10):1956-1959. |
| 贫血与弥漫大 B细胞淋巴瘤病人的预后相关性 |
| Correlation between anemia and the prognosis of patients with diffuse large B?cell lymphoma |
| |
| DOI：10.3969/j.issn.1009?6469.2019.10.012 |
| 中文关键词: 淋巴瘤，大 B细胞，弥漫性 血红蛋白类 无病生存 抗肿瘤联合化疗方案 因果律 贫血 |
| 英文关键词: Lymphoma,large B?cell,diffuse Hemoglobins Disease?free survival Antineoplastic combined chemotherapy protocols Causality Anemia |
| 基金项目: |
|
| 摘要点击次数: 2088 |
| 全文下载次数: 649 |
| 中文摘要: |
| 目的研究贫血指标 ——血红蛋白( hemoglobin，Hb)与弥漫大 B细胞淋巴瘤( diffuse large B?cell lymphoma，DLBCL)病人生存预后的关系。方法回顾性分析 2014年 6月至 2018年 3月在潍坊医学院附属医院( 48例)和潍坊市人民医院( 73例)确诊的共 121例 DLBCL病人的临床资料和随访资料。利用 Kaplan?Meier法绘制生存曲线并计算生存率，利用对数秩检验比较不同等级 Hb的 DLBCL病人的单因素生存率。使用 Cox比例风险回归模型进行影响 DLBCL病人生存预后的单因素和多因素分析。结果 Kaplan?Meier生存曲线显示， DLBCL病人 1年和 3年总生存率分别为 87.42%、72.56%；1年和 3年无进展生存率分别为 80.07%、52.95%。多因素 Cox比例风险回归分析发现如下因素均是影响 DLBCL病人无进展生存期的预后危险因素: Ann Arbor分期( OR＝3.376，95%CI:1.334~8.544)、骨髓浸润( OR＝3.269，95%CI:1.231~8.160)、 B症状( OR＝2.213，95%CI:1.016~4.817)、 Hb G2(100~80 g/L)(OR＝4.261，95%CI:1.108~16.390)、 Hb G3(＜ 80 g/L)(OR＝9.336，95%CI:2.475~35.219)。结论 Ann Arbor分期、骨髓浸润、 B症状、 Hb≥G2(＜ 100 g/L)与 DLBCL病人的无进展生存期的预后存在关系； DLBCL病人初诊时的贫血程度愈深，无进展生存期愈短。 |
| 英文摘要: |
| Objective To explore the relationship between the anemia index hemoglobin(Hb)and the survival and prognosis of diffuse large B?cell lymphoma(DLBCL)patients.Methods The retrospective analysis method was used to analyze the clinical da?ta and follow?up data of 121 DLBCL patients who had been diagnosed in The Affiliated Hospital of Weifang Medical College(48 cases)and Weifang People’s Hospital(73 cases)from June 2014 to March 2018.Kaplan?Meier method was used to draw the sur?vival curve and calculate the survival rate.Log?rank test was used to compare the single?factor survival rate of DLBCL patients withdifferent grades of Hb.Cox proportional hazard regression model was used for univariate and multivariate analysis of survival andprognosis of patients with DLBCL.Results The Kaplan?Meier survival curves showed that the 1?year overall survival rate and the 3?year overall survival rate of DLBCL patients were 87.42% and 72.56% respectively；the 1?year progression?free survival rate and 3?year progression?free survival rate were 80.07% and 52.95% respectively.Multivariate Cox proportional risk regression analysisshowed that Ann Arbor staging(OR＝3.376，95%CI:1.334?8.544)，bone marrow infiltration(OR＝3.269，95%CI:1.231?8.160)，B symptoms(OR＝2.213，95%CI:1.016?4.817)Hb G2(100?80 g/L)( OR＝4.261，95%CI:1.108?16.390)，Hb G3(＜ 80 g/L)(OR＝9.336，95%CI:2.475?35.219)wereriskfa，ctors for the prognosis of patients with DLBCL during progression free survival. Conclusions Ann Arbor staging，bone marrow infiltration，B symptoms，and Hb≥G2(＜ 100 g/L)were associated with the progno?sis of patients who were diagnosed with DLBCL.The severer the degree of anemia at the time of initial diagnosis，the shorter the pro? gression free survive. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
